Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Reading the DNA of fetuses is the next frontier of the genome revolution. Do you really want to know the genetic destiny of your unborn child?
Companies count DNA sequences in the blood of high-risk moms to test for Down syndrome and other large-scale disruptions, but they could do more.
In 2012, genomics tiptoed into the doctor’s office, gene therapy rose again, and man and machine united.
Software that enables collaboration between labs could make it easier for doctors to translate genome information.
Illumina wants a greater part of the reproductive-health market, says CEO Jay Flatley.
The promise of better drug design and genetic diagnoses spurs big pharma’s interest in sequencing technology.
The findings demonstrate how genome analysis could guide health-care decisions for healthy people.
A new program takes the research out of genomics.